Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

scientific article published on 9 February 2018

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11060-018-2797-5
P932PMC publication ID5942343
P698PubMed publication ID29427151

P50authorAdam KrętowskiQ24430625
Ewa MatyjaQ85632007
Magdalena Paczkowska-AbdulsalamQ89862384
Magdalena KaletaQ114529429
Marta Perek-PolnikQ47460874
Bożenna Dembowska-BagińskaQ47460875
Joanna TrubickaQ56839941
Bozena CukrowskaQ57561055
Wiesława GrajkowskaQ57637804
Maria LastowskaQ58656306
Monika DrogosiewiczQ59671926
Magdalena NiemiraQ59672413
Agnieszka Karkucinska-WieckowskaQ59708179
P2860cites workSubgroup-specific structural variation across 1,000 medulloblastoma genomesQ28271811
DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsiesQ28282708
Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcomeQ28298987
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological featuresQ33366431
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortQ33764662
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasQ34167499
Contrast enhancement pattern predicts poor survival for patients with non-WNT/SHH medulloblastoma tumoursQ35630417
Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesQ35837393
Medulloblastoma comprises four distinct molecular variantsQ36920479
Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.Q38374250
ALK Expression Is a Novel Marker for the WNT-activated Type of Pediatric Medulloblastoma and an Indicator of Good Prognosis for PatientsQ38879941
Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arraysQ43153279
Mir-449a, a potential diagnostic biomarker for WNT group of medulloblastoma.Q48162943
An operative staging system and a megavoltage radiotherapeutic technic for cerebellar medulloblastomas.Q54427712
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue2
P921main subjectmedulloblastomaQ1333608
P304page(s)231-240
P577publication date2018-02-09
P1433published inJournal of Neuro-OncologyQ15752119
P1476titleMedulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis
P478volume138

Reverse relations

cites work (P2860)
Q64065929A simplified approach using Taqman low-density array for medulloblastoma subgrouping
Q93023273Association of Aggresomes with Survival Outcomes in Pediatric Medulloblastoma
Q62492427MR Imaging-Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma
Q90270316Molecular Heterogeneity and Cellular Diversity: Implications for Precision Treatment in Medulloblastoma
Q97525026Molecular identification of CNS NB-FOXR2, CNS EFT-CIC, CNS HGNET-MN1 and CNS HGNET-BCOR pediatric brain tumors using tumor-specific signature genes
Q64087873Molecular markers and potential therapeutic targets in non-WNT/non-SHH (group 3 and group 4) medulloblastomas

Search more.